quickcal v.2.3 analysis template (Bangs Laboratories)
90
Structured Review
Bangs Laboratories
quickcal v.2.3 analysis template

Quickcal V.2.3 Analysis Template, supplied by Bangs Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/quickcal v.2.3 analysis template/product/Bangs Laboratories
Average 90 stars, based on 1 article reviews

Quickcal V.2.3 Analysis Template, supplied by Bangs Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/quickcal v.2.3 analysis template/product/Bangs Laboratories
Average 90 stars, based on 1 article reviews
quickcal v.2.3 analysis template - by Bioz Stars,
2026-06
90/100 stars
Images
1) Product Images from "Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia"
Article Title: Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia
Journal: Cell stem cell
doi: 10.1016/j.stem.2018.05.018
Figure Legend Snippet: KEY RESOURCES TABLE
Techniques Used: Control, Recombinant, Software, Enzyme-linked Immunosorbent Assay, Binding Assay